Selecting the right cells is vital to effective and reliable cell therapies, yet the cell-selection methods being used today are outdated and have not kept up with progress elsewhere in the field.

By selecting the right cell population, one with improved purity and yield, the overall process is greatly improved, enabling cell therapies to be more therapeutically effective.

We created a transformative technology for cell selection, whereby a microfluidic sorting process is used to provide a 43,000 cell per second sort rate. Our idea drew inspiration from bubble jet printers. By identifying that the creation of a bubble was technically possible, but insufficient to move a cell, we coupled this technique with the creation of a vortex. These two elements, when used in tandem, were able to efficiently and reliably move and select cells, providing a user-friendly method alongside a higher purity environment.

Starting with a blank page and drawing ideas from outside of the cell therapy industry, we utilised our team’s broad knowledge and expertise to create an entirely new system.

As customer trials begin, we are excited to see how this new, bespoke technology will enable the next generation of cell and gene therapies, and ultimately improve outcomes for patients.